Hasnyálmirigyrák: vizsgálatok itt: Finnország

In Finnország 13 Also abroad 1095

13 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 12.. Ask the study team whether a trial fits you.

3. fázisTaking people
A clinical trial of belzutifan and other treatments in people with solid tumors or von Hippel-Lindau (VHL)-related tumors (MK-6482-043)
Where
Helsinki, Tampere
Életkor
18 év and over
People
134 worldwide
Run by
Merck Sharp & Dohme LLC
See details and how to join2025-524160-38-00 · EU 2025-524160-38-00
1/2. fázisTaking people
A 2-part Phase 1/2 Open-label Trial on ODM-212
Where
Helsinki, Turku
Életkor
18 év and over
People
229 worldwide
Run by
Orion Corporation, Orion Pharma
See details and how to joinNCT07563738
3. fázisTaking people
A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma
Where
HUS, Tampere, Turku
Életkor
18 év and over
People
588 worldwide
Run by
Incyte Corporation
See details and how to joinNCT07522073
1/2. fázisTaking people
A Study to Test the Safety and Effectiveness of GSK5764227, Alone or With Other Treatments, in Participants With Advanced Gastrointestinal Cancers That Cannot be Surgically Removed (EMBOLD PanGI-201)
Where
Helsinki, Kuopio, Tampere
Életkor
18 év and over
People
346 worldwide
Run by
GlaxoSmithKline
See details and how to joinNCT06885034
3. fázisTaking people
A Randomized, Double-Blind, Phase 3 Study of Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D–Mutated Metastatic Pancreatic Ductal Adenocarcinoma (DAWN-303)
Where
Helsinki, Tampere, Turku
Életkor
18 év and over
People
239 worldwide
Run by
Incyte Corp.
See details and how to join2025-525009-18-00 · EU 2025-525009-18-00
No phaseTaking people
A Pan-European Post-Authorisation Safety Study: Risk of Pancreatic Cancer Among Type 2 Diabetes Patients Who Initiated Exenatide as Compared With Those Who Initiated Other Non-Glucagon-Like Peptide 1 Receptor Agonists Based Glucose Lowering Drugs
Where
Helsinki
Életkor
18 év to 99 év
People
24 000 worldwide
Run by
AstraZeneca
See details and how to joinNCT05663515
4. fázisTaking people
Preventing postoperative complications in patients undergoing high-risk pancreatoduodenectomy with a bundle approach including hydrocortisone, ocreotide, and teres ligament patch (PANENCA): an international randomized controlled multicenter trial
Where
Helsinki
Életkor
18 év and over
People
460 worldwide
Run by
Amsterdam UMC Stichting
See details and how to join2024-519667-18-00 · EU 2024-519667-18-00
3. fázisTaking people
Intensified treatment in patients with oligometastatic pancreatic cancer - multimodal surgical treatment versus systemic chemotherapy alone: a randomized controlled trial - METAPANC
Where
Helsinki
Életkor
18 év and over
People
500 worldwide
Run by
Universitaetsmedizin Goettingen
See details and how to join2023-503558-10-00 · EU 2023-503558-10-00
3. fázisNot yet taking people in Finnország
Neoadjuvant Treatment vs Upfront Surgery for Left-Sided Pancreatic Cancer
Where
Helsinki, Oulu
Életkor
18 év to 85 év
People
381
Run by
Helsinki University Central Hospital
See details and how to joinNCT07155629
2/3. fázisTaking people
Pancreatic Cancer Diagnosis With FAPI-PET Imaging
Where
Turku
Életkor
18 év to 85 év
People
100
Run by
Turku University Hospital
See details and how to joinNCT07098598
4. fázisTaking people
Pre- Vs. Postoperative Thromboprophylaxis in Pancreatic Surgery
Where
Helsinki, Oulu, Tampere
Életkor
18 év to 120 év
People
800 worldwide
Run by
Helsinki University Central Hospital
See details and how to joinNCT05245877
4. fázisTaking people
Prevention of thromboembolism during pancreatic cancer treatments - link to prognosis and relapse of the disease.
Where
Helsinki, Oulu, Tampere, Turku
Életkor
18 év and over
People
214
Run by
HUS-Yhtymae
See details and how to join2024-512475-12-01 · EU 2024-512475-12-01
2. fázisTaking people
Diagnostic Efficacy of 18F-FAPI-74 PET/CT in Patients with Pancreatic Cancer
Where
Turku
Életkor
18 év and over
People
100
Run by
Turku University Hospital
See details and how to join2023-510208-39-00 · EU 2023-510208-39-00